AI-generated summary
The authors report an open, single-group trial of LED red light therapy in 119 patients with primary dysmenorrhea, given 7 days before menstruation over three cycles. They report a 63.62% mean reduction in pain VAS scores and a 98.32% overall effective rate, and they conclude the therapy is safe and effective.
- Participants
- 119
- Who or what was studied
- Patients with primary dysmenorrhea
- Limits stated in the abstract
- The trial was open and single-group, with no control group, as the design name indicates.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
To evaluate the efficacy and safety of LED red light therapy in alleviating primary dysmenorrhea.
Methods
A total of 119 patients with primary dysmenorrhea were enrolled in 2022. The intervention was LED red light therapy administered 7 days before menstruation. Clinical outcomes were assessed after three menstrual cycles.
Results
After three cycles of treatment, the mean reduction rate in the Visual Analog Scale (VAS) score was 63.62%. The overall effective rate of the device was 98.32%. The total score of the COX Menstrual Symptom Scale decreased by 72.93%, with specific reductions of 72.55% in symptom severity and 73.26% in pain duration. No severe adverse events were reported during the trial. Only one adverse event (0.84%) was considered device-related.
Conclusion
LED red light therapy is safe and effective for the treatment of primary dysmenorrhea.
Trial Registration
ChiCTR2600116460.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Red light therapy, Visual analogue scale, Trial registration, Adverse event. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.